Roger Pomerantz
CIK: 0001614936
Transaction Breakdown
High conviction signal
Position reduction
Derivative conversions
Compensation grants
Gifts, tax withholding, conversions, dispositions to the issuer and other codes
Discretionary Trading P&L
Holdings
Transaction History (6 total)
- Jun 10, 2025INDP
Indaptus Therapeutics, Inc.
Award(A)DirectStock Option (right to buy)
30K shares- - Apr 10, 2025INDP
Indaptus Therapeutics, Inc.
Disposition(D)DirectStock Option (right to buy)
500 shares at avg. $0.50- - Apr 10, 2025INDP
Indaptus Therapeutics, Inc.
Disposition(D)DirectStock Option (right to buy)
250 shares at avg. $0.50- - Apr 10, 2025INDP
Indaptus Therapeutics, Inc.
Disposition(D)DirectStock Option (right to buy)
250 shares at avg. $0.50- - Nov 25, 2024VIRX
Viracta Therapeutics, Inc.
Exercise(M)Direct9K shares- - Aug 25, 2024VIRX
Viracta Therapeutics, Inc.
Exercise(M)Direct9K shares-
| Type | Shares | Price | Ownership | |||
|---|---|---|---|---|---|---|
| Jun 10, 2025 |  INDP Indaptus Therapeutics, Inc. | Award(A) Stock Option (right to buy) | 30,000 | - | - | Direct |
| Apr 10, 2025 | INDP Indaptus Therapeutics, Inc. | Disposition(D) Stock Option (right to buy) | 500 | $0.50 | - | Direct |
| Apr 10, 2025 | INDP Indaptus Therapeutics, Inc. | Disposition(D) Stock Option (right to buy) | 250 | $0.50 | - | Direct |
| Apr 10, 2025 | INDP Indaptus Therapeutics, Inc. | Disposition(D) Stock Option (right to buy) | 250 | $0.50 | - | Direct |
| Nov 25, 2024 |  VIRX Viracta Therapeutics, Inc. | Exercise(M) | 9,034 | - | $0 | Direct |
| Aug 25, 2024 | VIRX Viracta Therapeutics, Inc. | Exercise(M) | 9,034 | - | $0 | Direct |
1-6 of 6 transactions
About Pomerantz Roger
Pomerantz Roger (SEC CIK 0001614936) files insider reports with the SEC as Director of Enlivex Ltd. (ENLV), Director of Indaptus Therapeutics, Inc. (INDP) and Director of Viracta Therapeutics, Inc. (VIRX).
Signal8 holds 5 ownership filings by Pomerantz Roger (1 Form 3, 4 Form 4), filed between Sep 12, 2024 and Mar 18, 2026. Those filings report 6 transactions, from Aug 25, 2024 to Jun 10, 2025. Signal8's Form 4 history starts in Sep 2024.
The business address on Pomerantz Roger's filings is in CARDIFF, CA.
Recent filings by Pomerantz Roger
- Jun 10, 2025: Grant or award of INDP derivative securities (Form 4, code A).
- Apr 10, 2025: Disposition to issuer transactions of INDP derivative securities (3 lines, Form 4, code D).
- Nov 25, 2024: Option exercise of VIRX shares (Form 4, code M).
- Aug 25, 2024: Option exercise of VIRX shares (Form 4, code M).
Other insiders filing for Enlivex Ltd. (ENLV)
- Hershkovitz Oren, Chief Executive Officer
- Shlosberger Shachar, Chief Financial Officer
- Hart Gili, Director
- NOVIK SHAI A, Director
- Havron Avraham, Director
- Galamidi Einat, Chief Medical Officer